Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion type Assertion NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_head.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion description "[Over the last decade, inhibitors of PDE4 (a cAMP-specific family that negatively regulates the function of almost all pro-inflammatory and immune cells, and exerts widespread anti-inflammatory activity in animal models of asthma) have been developed with the view to reducing the adverse effects profile associated with non-selective inhibitors such as theophylline.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion evidence source_evidence_literature NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion SIO_000772 10730545 NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion wasDerivedFrom befree-20140225 NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.
- NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_assertion wasGeneratedBy ECO_0000203 NP644073.RA7cnxTD0vG2QbjkR8n36KAljL_yAS2GxxO_ONAVEcH24130_provenance.